Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion type Assertion NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_head.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion wasGeneratedBy ECO_0000203 NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion wasDerivedFrom befree-20150227 NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion SIO_000772 2037012 NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion evidence source_evidence_literature NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.